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Secretion principles are conserved from yeast to hu-
mans, and many yeast orthologs have established
roles in synaptic vesicle exocytosis in the mamma-
lian brain. Surprisingly, SEC4 orthologs and their ef-
fectors, the exocyst, are dispensable for synaptic
vesicle exocytosis. Here, we identify the SEC4 ortho-
log RAB3 and its neuronal effector, RIM1, as essen-
tial molecules for neuropeptide and neurotrophin
release from dense-core vesicles (DCVs) in mamma-
lian neurons. Inactivation of all four RAB3 genes
nearly ablated DCV exocytosis, and re-expression
of RAB3A restored this deficit. In RIM1/2-deficient
neurons, DCV exocytosis was undetectable. Full-
length RIM1, but not mutants that lack RAB3 or
MUNC13 binding, restored release. Strikingly, a short
N-terminal RIM1 fragment only harboring RAB3- and
MUNC13-interacting domains was sufficient to sup-
port DCV exocytosis. We propose that RIM and
MUNC13 emerged as mammalian alternatives to
the yeast exocyst complex as essential RAB3/SEC4
effectors and organizers of DCV fusion sites by re-
cruiting DCVs via RAB3.
INTRODUCTION
Secretion mechanisms are highly conserved across species
and rely on ancient principles. In yeast Saccharomyces cerevi-
siae, 23 proteins were initially identified to drive the secretory
pathway (Novick et al., 1980, 1981; Novick and Schekman,
1979), of which ten, SEC1–6, 8–10, and 15, act in the last steps
of secretion (Novick et al., 1981), together with SNC1/2 (Protopo-
pov et al., 1993) and SSO1/2 (Aalto et al., 1993). Subsequent
research revealed that orthologs for many of these proteins drive
regulated secretion of synaptic vesicles (SVs) in mammalian
neurons (Jahn and Scheller, 2006; Kaeser and Regehr, 2014;
S€udhof, 2013; S€udhof and Rothman, 2009). Strikingly, among
the ten SEC genes that act in the last steps, only two have estab-Neurlished roles in mammalian SV fusion, SEC1 (MUNC18) and
SEC9 (SNAP25). Orthologs of the other eight—encoding the
GTPase SEC4 and its effectors; SEC2, a guanine exchange fac-
tor for SEC4 (Walch-Solimena et al., 1997); and 6 subunits of the
SEC4 effector complex called the exocyst complex, SEC3, 5, 6,
8, 10, and 15 (Bowser et al., 1992; Guo et al., 1999; TerBush
et al., 1996; TerBush and Novick, 1995)—are largely dispensable
for SV fusion (Mehta et al., 2005; Murthy et al., 2003; Schl€uter
et al., 2004, 2006; Schwenger andKuner, 2010). The role of these
orthologs in regulated secretion in mammalian neurons remains
poorly understood.
RAB3 proteins, orthologs of yeast SEC4p (Zahraoui et al.,
1989), are highly expressed in brain (Fischer von Mollard
et al., 1990; Schl€uter et al., 2002) and dynamically associate
with SVs (Fischer von Mollard et al., 1990; Takamori et al.,
2006). Null mutant mice, lacking all four mammalian RAB3
paralogs (RAB3A–D, RAB3 QKO from hereon), show perinatal
lethality but only subtle changes in synaptic transmission
(Schl€uter et al., 2004, 2006), in contrast to the essential func-
tion of SEC4p in vesicle secretion in yeast (Novick et al., 1980;
Salminen and Novick, 1987). RAB3A null mice, which are ho-
mozygous viable and have minor changes in synaptic trans-
mission (Geppert et al., 1997), show several altered behaviors,
including circadian rhythmicity (Kapfhamer et al., 2002),
reversal learning and exploration (D’Adamo et al., 2004), mem-
ory precision (Ruediger et al., 2011), and ethanol responses
(Kapfhamer et al., 2002), although other mnemonic capabilities
were normal (Hensbroek et al., 2003). These data suggest
important, as yet unidentified, roles of mammalian RAB3
proteins.
Neuropeptides, neurotrophins, and other signaling mole-
cules, together referred to as neuromodulators, are secreted
by dense-core vesicles (DCVs) and control diverse physiolog-
ical functions such as brain development, synaptic plasticity,
circadian rhythm, and many behaviors and emotions (Cheng
et al., 2011; Malva et al., 2012; Mertens et al., 2007; Meyer-Lin-
denberg et al., 2011; Pang et al., 2004). Defects in neuromodu-
lator signaling are associated with psychiatric disorders,
obesity, and diabetes (Meyer-Lindenberg et al., 2011; V€ah€atalo
et al., 2015). While SV fusion principles are well characterized,
many fundamental questions remain unanswered for neuromo-
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Here, we identify SEC4-ortholog RAB3 and its mammalian
effector, RIM, as essential molecules for regulated secretion of
neuromodulators from DCVs in mammalian neurons. We used
hippocampal excitatory neurons to describe essential compo-
nents of the DCV secretory pathway. We show that, unlike the
previously reported (mild) effects on SV fusion (Schl€uter et al.,
2006), DCV fusion was reduced by >90% in RAB3 QKO neurons.
Furthermore, in RIM-deficient conditional double-knockout
(cDKO) neurons, DCV fusion was completely lost. N-terminal
RAB3- and MUNC13-interacting domains of RIM co-trafficked
with DCVs in a RAB3-dependent manner and were sufficient to
fully restore DCV fusion. We propose that RIMs and MUNC13
emerged as mammalian alternatives to the yeast exocyst com-
plex as essential RAB3/SEC4 effectors and organizers of DCV
fusion sites by positioning MUNC13 and recruiting DCVs
via RAB3.
RESULTS
Deletion of All RAB3 Proteins Severely Impairs DCV
Fusion
The involvement of mammalian RAB3 proteins in release of neu-
romodulators was assessed by recording DCV fusion in single
hippocampal neurons on glia micro-islands from RAB3 QKO
and wild-type mice at days in vitro 14 (DIV 14; Figure 1A).
Expression of neuropeptide Y (NPY) fused to pH-sensitive
EGFP (pHluorin) using lentivirus targets this reporter to virtually
all DCVs, with >90% overlap with endogenous neurotrophin
BDNF and neuropeptide co-factors chromogranins A/B and
without altering the total number of DCVs per neuron (Domi-
nguez et al., 2018; Persoon et al., 2018). Hence, this reporter
labels DCVs irrespective of their endogenous neuropeptide
and neurotrophin content and can be used to study their gen-
eral secretion principles applicable to many cargo types. The
NPY-pHluorin reporter detects single DCV fusion events by an
instant increase of fluorescence due to rapid deacidification
of the vesicle’s interior when the fusion pores open (Figure 1B;
Arora et al., 2017; Emperador Melero et al., 2017; Farina et al.,
2015; Persoon et al., 2018; van Keimpema et al., 2017). Upon
calcium influx induced by action potential trains (16 bursts of
50 action potentials [APs] at 50 Hz; Balkowiec and Katz,
2002; de Wit et al., 2009; G€artner and Staiger, 2002; HartmannFigure 1. RAB3 Deletion Impairs DCV Fusion
(A) Representative composite confocal image of single cultured hippocampal n
green), axons (SMI312, blue), and DCVs (CHGB, red) were labeled. Scale bars: 4
(B) NPY-pHluorin as optical reporter for DCV fusion. Repetitive electrical stimulati
show a single DCV fusion event reported by NPY-pHluorin, with DF/F0 (inset belo
DCV lumen (a). Upon depolarization-induced Ca2+-influx, the DCV fusion pore ope
upon cargo release or fusion pore closure and vesicle reacidification (c). Right pa
upon NH4 superfusion (Total pool), Synapsin-ECFP labeled synapses (SynECFP
(C–H) DCV fusion analysis using NPY-pHluorin in single wild-type or RAB3ABCD
graph of DCV fusion events per cell. Mann-Whitney U test: ****p < 0.0001. (F) Histog
for RAB3A+/+BCD/, RAB3ABCD/, or RAB3ABCD/ expressing RAB3A, -B, -
correction: *p < 0.05, **p < 0.01, ***p < 0.001. ns = non-significant, p > 0.05.
See also Figures S1 and S2.
In all figures: repetitive electrical stimulation (16 trains of 50 APs at 50 Hz) is repre
experiments and number of single neuron observations in brackets. Individual n
detailed statistics) is shown in STAR Methods.et al., 2001; Matsuda et al., 2009; van de Bospoort et al., 2012),
DCV fusion in RAB3 QKO neurons was almost absent (Figures
1C–1E), showing an 20-fold reduction as compared to wild-
type neurons (Figures 1C–1E). The loss of DCV fusion in RAB3
QKO neurons was confirmed using BDNF as an independent re-
porter for neuromodulator release (Figures S1A–S1E). Taken
together, these data indicate that RAB3 is a key factor in neuro-
modulator release from DCVs.
We excluded several potentially confounding factors that
could, in principle, contribute to this major reduction in DCV
fusion: (1) the number of NPY-pHluorin-labeled DCVs per
neuron was similar between genotypes (Figure S1F); (2) the
temporal distribution of fusion before and during stimulation
(Figures S1G and S1H) and (3) calcium dynamics (Figure S1I)
were also similar; (4) the location of fusion events, synaptic or
extra-synaptic, did not differ between wild-type and RAB3
QKO neurons (Figures S1K and S2A–S2C); (5) the number of
synapses and the total dendritic length of wild-type,
RAB3A+/+, BCD/ (RAB3 triple knockout [TKO]), and RAB3
QKO neurons were similar (Figures S2D–S2G), as observed
before (Schl€uter et al., 2006); (6) the fluorescence intensity of
VGLUT1 (Figure S2H) at synapses was not altered in RAB3
QKO neurons; and (7) the number and distribution of puncta
labeled with the endogenous DCV marker chromogranin B
(CHGB) was similar between genotypes (Figures S2I–S2L and
S2O). While the number of CHGB puncta and total CHGB pro-
tein levels (Figure S2N) was similar between RAB3 QKO and
control neurons, the intensity of CHGB puncta (Figure S2M)
and intensity of individual DCV fusion events (Figure S1J)
were slightly, but significantly, reduced (<20%), indicating a
possible mild impairment in DCV loading. Together, these
data exclude several potentially confounding effects and
strengthen the conclusion that RAB3 proteins are important
regulators of DCV fusion.
To test for functional redundancy between RAB3A–D
(Schl€uter et al., 2002), we expressed each paralog in RAB3
QKO neurons and analyzed DCV fusion events (Figures 1F–
1H). Re-expression of RAB3A, RAB3C, and RAB3D, but not
RAB3B, restored the number of DCV fusion events to levels
that were not significantly different from RAB3 TKO neurons
(Figures 1F–1H). However, only re-expression of RAB3A
significantly increased DCV fusion, compared to RAB3 QKOeurons from wild-type (left) or RAB3ABCD/ (right) mice. Dendrites (MAP2,
0 mm.
on (16 trains of 50 APs at 50 Hz) is represented by blue bars. Middle panels a–c
w). Scale bar: 1 mm. NPY-pHluorin is quenched in the acidic environment of the
ns indicated by a rapid increase in fluorescence (b), followed by a rapid decline
nels: DCV fusion events during stimulation (Stimulation), total number of DCVs
; Figures S2A–S2C). Scale bar: 5 mm.
/ hippocampal neurons. (C) Histograms, (D) cumulative plot, and (E) summary
rams, (G) cumulative plot, and (H) summary graph of DCV fusion events per cell
C, or -D neurons, normalized to RAB3A+/+ BCD/. Kruskal-Wallis with Dunn’s
sented by blue bars. All data shown as mean ± SEM. N represents number of
eurons are represented as dots. Detailed information (average, SEM, n, and






































































































Figure 2. RIM Depletion Blocks DCV Fusion
(A) Representative composite confocal image of single hippocampal control (left) or RIM 1/2 cDKO (right) neurons. Dendrites (MAP2, green), axons (SMI312,
blue), and DCVs (CHGB, red) were labeled. Scale bars: 20 mm.
(B) NPY-pHluorin and NPY-mCherry as dual-color optical reporters for DCV fusion. Lower panels a–c show a single DCV fusion event reported by NPY-pHluorin
and NPY-mCherry, withDF/F0 traces (green, NPY-pHluorin; red, NPY-mCherry). Right panels: DCV fusion events during stimulation (Stimulation), total number of
DCVs upon NH4 superfusion (Total pool), and Synapsin-ECFP labeled synapses (SynECFP). Scale bar (left): 1 mm; scale bar (right): 5 mm.
(C–E) DCV fusion analysis using NPY-pHluorin and NPY-mCherry in single hippocampal control (black) or RIM1/2 cDKO (red) neurons. (C) Histograms, (D)
cumulative plot, and (E) summary graph of DCV fusion events per cell. Mann-Whitney U test: ***p % 0.0002.
See also Figures S3–S6.neurons (Figures 1F–1H). The expression levels of rescue con-
structs (Figures S1L and S1M) and number of NPY-pHluorin-
labeled DCVs per neuron (Figure S1N) were similar between
each condition. Together, these data suggest that RAB3C
and RAB3D partially restore DCV release but less efficiently
than RAB3A, while RAB3B does not rescue DCV release.
RIM1 Is Essential for DCV Fusion
RIM1/2 proteins, multi-domain scaffolding proteins enriched
at presynaptic active zones, are established mammalian
RAB3A/C effectors at the target membrane (Wang et al.,
1997). To test if RIM1/2 are important in DCV fusion, we
used single isolated hippocampal neurons from conditional
RIM1/RIM2 DKO mice in which Cre-recombinase deletes
expression of all RIM 1 (a and b) and RIM 2 (a, b, and g)
isoforms (Kaeser et al., 2011). Hippocampal neurons (Fig-
ure 2A) were infected at DIV 0 with lentiviral constructs ex-
pressing active, EGFP-tagged Cre-recombinase (RIM cDKO),1068 Neuron 104, 1065–1080, December 18, 2019resulting in the absence of RIM protein expression from DIV
8 (Figure S3A), or inactive, EGFP-tagged mutant Cre-recombi-
nase (control). To test if RIMs function in neuromodulator
release, DCVs were co-labeled with NPY-pHluorin and NPY
fused to red fluorescent mCherry (NPY-mCherry), which,
upon DCV fusion, shows a rapid decrease in fluorescence
due to cargo diffusion (Figure 2B). NPY-mCherry allows for
analysis of DCV transport and behavior prior to fusion, as
mCherry does not quench in the low pH of the DCV lumen
(Figure 2B). RIM cDKO neurons showed a more than 95%
reduction in NPY-mCherry-labeled DCV fusion events upon
stimulation, compared to controls (Figures 2C–2E; Figure S3B).
The few remaining events in RIM cDKO neurons occurred
mostly outside synapses (Figure S3C), of which the fluores-
cence disappeared within 1 s (Figures S3D and S3E), and
were not detected as NPY-pHluorin-labeled fusion events
(Figures S3F and S3G). The total number of NPY-mCherry
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in RIM cDKO neurons was confirmed using BDNF-pHluorin as
an independent reporter for neuromodulator release (Figures
S3J–S3L).
Morphological characterization at DIV 14 showed a
modestly reduced number of synapses and MUNC13 intensity
when Cre-recombinase was expressed at DIV 0 (Figures S4A–
S4G). No differences were found in the number or intensity
of CHGB puncta (Figures S4A and S4H–S4L). CHGB puncta
co-localized slightly more with VGLUT1-positive synapses
compared to control (Figures S4M and S4N), and synaptic
electron micrograph sections showed a trend toward accumu-
lation of DCVs at the presynapse (Figures S4O and S4P).
DCVs are actively transported throughout the neuron by
microtubule-based motor proteins (Lo et al., 2011; Stucchi
et al., 2018; Zahn et al., 2004), but DCV transport parameters
(speed, distance moved) were not altered in RIM cDKO neu-
rons (Figures S5A–S5H). Hence, RIM cDKO neurons have
fewer synapses when Cre-infected at DIV 0 with a trend for
DCV accumulation but have a normal DCV population, indi-
cating that RIMs are not required for DCV biogenesis, loading,
or transport.
To test if reduced synapse numbers could explain the DCV
fusion phenotype, we expressed Cre-recombinase at DIV 5
instead of DIV 0, which does not affect synapse numbers (Fig-
ures S5I–S5L), and observed a similar block in DCV fusion in
RIM-deficient neurons at DIV 18 (Figures S5M–S5O), showing
that changes in synapse number do not correlate with a reduc-
tion in DCV fusion in RIM-deficient neurons. Cre-recombinase
expression in wild-type neurons did not negatively affect DCV
fusion (Figures S5P–S5R). Together, we conclude that RIMs
are essential for DCV fusion.
To study whether RIM1 or RIM2 is required for DCV fusion,
single hippocampal neurons from RIM1 cKO mice or RIM2
cKO mice were infected with Cre-recombinase or control virus
at DIV 0. Upon stimulation, RIM2-deficient neurons (RIM1+/+,
RIM2/) showed a similar number of DCV fusion events
compared to controls, while DCV fusion was strongly reduced
in RIM1-deficient neurons (RIM1/, RIM2+/+ and RIM1/,
RIM2+/) and RIM2-deficient neurons heterozygous for RIM1
(Figures S6A–S6F). Multiple bursts of APs were required to
trigger DCV fusion in RIM1-deficient neurons (Figures S6B
and S6C). Total DCV numbers were similar in all genotypes
(Figure S6E). These data show that RIM1 is required for effi-
cient DCV fusion and, in absence of RIM1, RIM2-dependent
DCV fusion is strongly reduced and delayed.Figure 3. N Terminus Interactions of RIM1/2 Regulate DCV Fusion
(A) Domain structure of full-length RIM1a (left) with key interactions. Diagram of
cDKO neurons (right). Zn, zinc-finger domain with surrounding a-helical regions; P
tag; asterisk, K144/6E substitution.
(B–D) DCV fusion analysis using NPY-pHluorin in single control or RIM cDKO hipp
Histograms, (C) cumulative plot, and (D) summary graph of DCV fusion events per c
p > 0.05.
(E) Kymograph and (F) average normalizedDF/F0 traces of intracellular calcium (Flu
cDKO neurons at synaptic (labeled by Synapsin-ECFP) or extra-synaptic regions
(G–I) DCV fusion analysis using NPY-pHluorin in single control or RIM cDKO hi
Histograms, (H) cumulative plot, and (I) summary graph of DCV fusion events pe
See also Figure S6.
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Regulate DCV Fusion
RIMs regulate synaptic vesicle fusion through interactions with
MUNC13, voltage-gated calcium channels, and PIP2 (Figure 3A
[left]; de Jong et al., 2018; Deng et al., 2011; Han et al., 2011;
Kaeser et al., 2011). To study if these interactions are required
for DCV fusion, we expressed multiple RIM-rescue constructs
(Figure 3A) in RIM cDKO neurons from DIV 0, which were ex-
pressed at similar levels and all localized to synaptic regions
at DIV 14 (Figures S6G and S6H), as reported before (Kaeser
et al., 2011). Upon stimulation, full-length RIM1a rescued
DCV fusion to control levels (Figures 3B–3D). RIM1b lacks inter-
action with RAB3 (Kaeser et al., 2008), which binds RIM1a
through the N-terminal a helix (Figure 3A; Wang et al., 1997).
DCV fusion in RIM1b-expressing RIM cDKO neurons was
reduced by almost 75% compared to controls (Figures 3B–
3D). RIM1a-DPDZ, lacking the PDZ domain that binds to
voltage-gated calcium channels (Figure 3A; Kaeser et al.,
2011), almost completely rescued DCV fusion in RIM cDKO neu-
rons (Figures 3B–3D). MUNC13 binds to the N-terminal zinc
finger of RIM (Betz et al., 2001; Dulubova et al., 2005; Schoch
et al., 2002), and mutating two lysine residues (K144 and K146)
of RIM to glutamates (RIM1a-K144/6E, Figure 3A) results in a
loss of MUNC13 binding (Deng et al., 2011; Dulubova et al.,
2005; Lu et al., 2006). Expression of RIM1a-K144/6E in RIM
cDKO neurons did not restore DCV fusion (Figures 3B–3D).
Neither the onset of fusion nor the total pool was altered (Figures
S6I and S6J), but the percentage of synaptic fusion events
was increased in the different rescue conditions (Figure S6K),
in line with their synaptic expression (Figures S6G and S6H).
These data show that the N-terminal interactions of RIMs with
RAB3 and MUNC13 are essential for efficient DCV fusion.
To confirm that RIM interaction with voltage-gated calcium
channels is not essential for DCV fusion, we first measured cal-
cium influx using Fluo5-AM in synaptic and extra-synaptic re-
gions. Both RIM cDKO neurons and control neurons showed
a calcium influx profile corresponding with the bursts of repeti-
tive stimulation (Figures 3E and 3F). In RIM cDKO neurons, mul-
tiple bursts of activity were required to reach maximum fluores-
cence (Figures 3E and 3F). Next, we applied the calcium
ionophore ionomycin to increase intracellular calcium levels
independently of voltage-gated calcium channels. Ionomycin
(5 mM) elicited robust DCV fusion in control but not in RIM
cDKO neurons (Figures 3G–3I, S6L, and S6M). From these
data, we conclude that a defect in calcium entry or location ofRIM1b, RIM1a-DPDZ, and RIM1a-K144/6E rescue proteins expressed in RIM
xxP, proline-rich region; H, location of a human influenza hemagglutinin (HA)-
ocampal neurons without or with rescue constructs (RIM cDKO + rescue). (B)
ell. Kruskal-Wallis with Dunn’s correction: *p < 0.05, **p < 0.01, ***p < 0.001. ns,
o5-AM) levels upon repetitive electrical stimulation (blue bars) in control or RIM
.
ppocampal neurons upon 30 s application of 5 mM ionomycin (blue bar). (G)
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RIM Ca2+
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Figure 4. Expression of MUNC13 Rescues DCV Fusion in RIM cDKO Neurons
(A) Diagram of MUNC13-2 wild-type (WT) and MUNC13-2 (DN) rescue proteins expressed in RIM cDKO neurons. Key domains and interactions are indicated.
Constructs were labeled at the C terminus with mCherry to visualize expression (not indicated).
(B–E) DCV fusion analysis using NPY-pHluorin in single control or RIM cDKO hippocampal neurons without or with expression of full-length RIM1a (gray),
MUNC13-2 WT (purple), or MUNC13-2 (DN) (magenta). (B) Histograms, (C) cumulative plot, (D) normalized cumulative plot of first 10 s of stimulation, and (E)
summary graph of DCV fusion events per cell. Kruskal-Wallis with Dunn’s correction: ***p < 0.001. ns, p > 0.05.
See also Figure S7.voltage-gated calcium channels cannot explain the lack of DCV
fusion in RIM cDKO neurons.
Overexpression of MUNC13 Rescues DCV Fusion in RIM
cDKO Neurons
RIMs prime synaptic vesicle fusion by converting an autoinhibi-
tory MUNC13 homodimer into an activated heterodimer by
interaction of the RIM Zn2+ finger with the C2A domain ofMUNC13 (Camacho et al., 2017). To test whether activation of
MUNC13 is required for DCV fusion, we expressed wild-type
ubMUNC13-2 (Figure 4A, left) or N-terminally truncated ub-
MUNC13-2 (Figure 4A, right; MUNC13-2 DN), which does not
interact with RIM1a or form homodimers (Deng et al., 2011), in
RIM cDKO neurons. Overexpression of MUNC13-2 (WT) or
MUNC13-2 (DN) restored DCV fusion (Figures 4B–4E and S7A–
S7D), although RIM-deficient cDKO neurons expressingNeuron 104, 1065–1080, December 18, 2019 1071
MUNC13-2 (DN) required multiple bursts of stimulation before
DCV fusion to peak (Figure 4D). These results show that overex-
pression of MUNC13-2 rescues DCV fusion in RIM cDKO neu-
rons and that the N-terminal C2A domain of MUNC13-2 is not
required for DCV fusion. Furthermore, the data suggest that
MUNC13 supports DCV fusion independent of RIM when
overexpressed.
N-Terminal Domain of RIM1a Is Sufficient to Support
DCV Fusion
To test if the N-terminal interactions of RIMs are sufficient to sup-
port DCV fusion, we expressed different N-terminal RIM1 frag-
ments in RIM cDKO neurons (Figure 5A; Deng et al., 2011).
Rescue with the N-terminal RIM1a fragment containing RAB3-
and MUNC13-binding sequences (RIM1a-RZ) fully restored
DCV fusion (Figures 5B–5D and S7E–S7I). Expression of
RIM1b-Z, which lacks RAB3 binding but still binds MUNC13,
rescued DCV fusion in RIM cDKO neurons but significantly lower
compared to control (Figures 5B–5D and S7E–S7I, similar to
full-length RIM1b, Figure 3D). Both the N-terminal RIM1a and
RIM1b fragments containing the Zn2+-finger mutations elimi-
nating MUNC13 binding (RIM1a-RZ-K144/6E and RIM1b-Z-
K144/6E) did not restore DCV fusion in RIM cDKO neurons (Fig-
ures 5B–D and S7E–S7I). Together, these data show that the
N-terminal fragment of RIM is sufficient to support DCV fusion,
and it does so with more efficiency than for synaptic vesicle
fusion (Deng et al., 2011). Furthermore, interactions with both
RAB3 and MUNC13 are important.
N Terminus of RIM Interacts with DCVs through RAB3A
RAB3 binds to SVs (Fischer von Mollard et al., 1990) and to se-
cretogranin II-positive secretory granules in PC12 cells (Handley
et al., 2007). To assess whether RAB3A is present on DCVs in
hippocampal neurons, colocalization experiments were per-
formed in RAB3 QKO neurons expressing RAB3A-mCherry
and NPY-pHluorin (Figure 6A). RAB3A-mCherry was found in
stationary deposits at synapses (Figure 6A), co-transported
with NPY-pHluorin (Figure 6A; yellow lines) or transported
without colocalizing with NPY-pHluorin (Figure 6A). Also, moving
NPY-pHluorin puncta negative for RAB3A-mCherry were found
(Figure 6A; green lines). These data suggest that RAB3A is trans-
ported on a subset of DCVs.
RIMs are expressed at the presynaptic active zone (Wong et al.,
2018). To investigate if RIMs also interact with DCVs, we infected
neurons with full-length mCherry-tagged RIM1 but did not obtain
sufficient expression. However, the mCherry-tagged, N-terminal
RIM rescue construct (RIM1a-RZ-mCherry) did express well
enough to study transport of RIM1a-RZ-mCherry and NPY-
pHluorin in RIM cDKO neurons (Figure 6B). RIM1a-RZ-mCherry
was predominantly located at synapses (Figure 6B) but also co-
transported with a subset of NPY-pHluorin-labeled vesicles
outside synapses (Figure 6B; yellow lines). We hypothesized that
the interaction between DCVs and the N terminus of RIM1a is
mediated by RAB3A. To test this, the percentage of moving
NPY-pHluorin-labeled DCVs positive for RIM1a-RZ-mCherry
wasquantified inRAB3QKOneuronsandRIMcDKOneurons (Fig-
ures 6C and 6D). In RIM cDKO neurons, approximately 33% of
movingNPY-pHluorin puncta co-transportedRIM1a-RZ-mCherry1072 Neuron 104, 1065–1080, December 18, 2019(Figure6D;black),while inRAB3QKOneuronsonly 11.5%ofmov-
ing NPY-pHluorin puncta were positive for RIM1a-RZ-mCherry
(Figure 6D; gray). Hence, in RAB3 QKO neurons, the interaction
of DCVs with the N terminus of RIMs is partly lost, suggesting
RIMs interact with DCVs mainly through RAB3.
To test if RAB3A and RIMs are transported together on DCVs,
NPY-pHluorin, RIM1a-RZ-ECFP, and RAB3A-mCherry were co-
expressed in RAB3 QKO neurons (Figure 6E) or wild-type neu-
rons (Figure S8A). Moving NPY-pHluorin puncta colocalized
with RIM1a-RZ (Figures 6E and S8A; white), with RAB3A (Figures
6E and S8A; yellow), and co-transport of NPY with RAB3A and
RIM1a-RZ (Figures 6E and S8A; magenta). These data suggest
that RAB3A and RIM1a-RZ are transported together on a subset
of DCVs.
To test if MUNC13 and RIMs are transported together on
DCVs, NPY-pHluorin, RIM1a-RZ-ECFP, and MUNC13-2-
mCherry were co-expressed in wild-type neurons (Figure S8B).
Endogenous MUNC13 localizes predominantly to synapses,
with little immunoreactivity colocalizing with an endogenous
DCV marker outside synaptic regions (Figures S8C–S8E). How-
ever, MUNC13-mCherry colocalizes with moving NPY-pHluorin
puncta positive for RIM1a-RZ (Figure S8B; magenta). This co-
trafficking of MUNC13 and RIM1a with DCVs suggests that
MUNC13 and RIMs may form heterodimers on DCVs, and RIM
activates MUNC13 already while traveling through the axon.
However, the limited evidence for colocalization of endogenous
MUNC13 and DCVs and the fact that live imaging of full-length
RIM was not feasible prevents strong conclusions.
DISCUSSION
In this study, we identify essential roles for RAB3 and RIM1/2 in
neuromodulator release in mammalian CNS neurons. RAB3
QKO neurons showed a 20-fold decrease in DCV fusion and
RIM1/2 cDKO neurons a 100-fold decrease. DCV fusion in RIM
cDKO neurons was rescued by expression of wild-type RIM1a
but not RAB3- or MUNC13-binding-deficient RIM1 mutants.
The N-terminal fragment of RIM1 that interacts with RAB3 and
MUNC13 was sufficient to fully restore DCV fusion. This N-termi-
nal fragment also co-trafficked with DCVs via RAB3. We
conclude that RIMs are essential RAB3 effectors for mammalian
neuromodulator release and organize DCV fusion by positioning/
activating MUNC13 and recruiting DCVs through RAB3 interac-
tions (Figure 7), in analogy to the exocyst complex in yeast.
To our knowledge, the RIM1/2 null DCV fusion phenotype is
stronger than any other null mutation studied so far: in
MUNC13-1/2 DKO neurons, 40% of DCV fusion events remain
(van de Bospoort et al., 2012), 10%–40% remain in the
CAPS1/2 DKO (Farina et al., 2015; van Keimpema et al., 2017),
and 10%–20% remain upon deletion of SNAREs, i.e., SNAP25
knockout/down or TeTx expression (Arora et al., 2017; Shimojo
et al., 2015). RIM-deficient neurons showed a 100-fold reduction
in evoked DCV fusion (approximately 0.75 fusion events per cell
[72 events in 96 cells], compared to approximately 70 events per
cell in controls [5,063 events in 72 cells]). Hence, RIMs are
required for neuromodulator release in hippocampal neurons,
and no redundant pathways exist. Furthermore, it is evident
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Figure 5. RIM1a N-Terminal Domain Is Sufficient to Restore DCV Fusion in RIM cDKO Neurons
(A) Diagram of N-terminal wild-type and mutant RIM rescue domains expressed in RIM cDKO neurons. Key domains and interactions are indicated. Zn, zinc-
finger domain with surrounding a-helical regions; H, location of a HA-tag; asterisk, K144/6E substitution.
(B–D) DCV fusion analysis using NPY-pHluorin in single control or RIM cDKO hippocampal neurons without or with expression of full-length RIM1a (gray) or
N-terminal rescue constructs (RIM cDKO + rescue). (B) Histogram, (C) cumulative plot, and (D) summary graph of DCV fusion events per cell. Kruskal-Wallis with
Dunn’s correction: *p < 0.05, **p < 0.01, ***p < 0.001. ns, p > 0.05.
See also Figure S7.Finally, the almost complete loss of NPY-pHluorin or BDNF-
pHluorin events in the absence of RIM1/2 also confirms the
specificity of the DCV-fusion reporters, because synaptic vesicle
exocytosis is less strongly impaired in RIM1/2 cDKO neurons (de
Jong et al., 2018; Kaeser et al., 2011).RAB3A Regulates the Mammalian DCV Secretory
Pathway at a Late Step, Analogous to SEC4p in Yeast
Since the original discovery that the ras-like, GTP-binding pro-
tein SEC4p is one of the essential components in the last step
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Figure 6. RIM N Terminus Interaction with DCVs Is Reduced in RAB3-Deficient Neurons
(A) Representative kymograph showing trajectories of DCVs (NPY-pHluorin, green) and RAB3A-mCherry (red) in RAB3ABCD/ neurons. Synapsin-ECFP labels
synapses (above kymograph). NPY-only transport (green) and co-transport of NPY and RAB3A (yellow) is indicated by overlays.
(B) Representative kymograph showing trajectories of DCVs (NPY-pHluorin, green) and N-terminal fragment RIM1a-RZ-mCherry (red) in RIM cDKO neurons.
Synapsin-ECFP labels synapses (above kymograph). NPY-only transport (green) and co-transport of NPY and RIM1a-RZ-mCherry (yellow) is indicated by
overlays.
(legend continued on next page)
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Figure 7. Function of RAB3, RIM, and MUNC13 in DCV Fusion
In yeast (left), secretory vesicle binding to the plasma membrane (top, left) relies on the interaction between SEC4 (RAB3) and the Exocyst complex before
SNARE-mediated fusion (bottom, left). In mammalian neurons (right), RAB3, RIM, and MUNC13 regulate the late steps in DCV fusion. Through N-terminal in-
teractions, RIMs position MUNC13 and recruit DCVs via RAB3, which is located on the vesicle (top, right). After this step, action potential-triggered, SNARE-
mediated fusion can occur (bottom, right). These interactions are essential for the organization of DCV fusion sites, in analogy to the exocyst complex in yeast. Zn,
zinc-finger domain.of the RAB protein family have been found to regulate many
intracellular fusion reactions (see for a review: Galvez et al.,
2012). RAB3A has been considered to serve a similar role as
SEC4p in the mammalian brain due to the high homology to
SEC4p, high expression levels in brain, and dynamic association
to synaptic vesicles (Fischer von Mollard et al., 1990; Takamori(C) Example kymographs of NPY-pHluorin and RIM1a-RZ-mCherry transport in R
yellow lines.
(D) Quantification of co-transport of NPY-pHluorin with RIM1a-RZ-mCherry in RIM
per cell were quantified for trafficking with or without RIM1a-RZ-mCherry. Percen
(E) Example kymograph of co-transport of NPY-pHluorin with RIM1a-RZ-ECFP
indicates transport of NPY (green), co-transport of NPY with RAB3A (yellow), NP
Neurons were imaged in the presence of Tyrode’s solution containing 50 mM NH
See also Figure S8.et al., 2006; Zahraoui et al., 1989). Furthermore, RAB3A regu-
lates secretory granule fusion in pancreatic beta cells (Yaekura
et al., 2003), PC12 cells (Tsuboi and Fukuda, 2006), and sperm
(Bustos et al., 2012), but synaptic transmission in RAB3A-
knockout mice is only mildly affected (Geppert et al., 1997),
and deficiency for all four RAB3 paralogs hardly affects synapticIM cDKO (top) and RAB3 QKO (bottom) neurons. Co-transport is indicated by
cDKO (black) and RAB3 QKO (gray) neurons. A subset of moving NPY puncta
tage of moving NPY co-trafficking with RIM1a-RZ-mCherry per cell is shown.
and RAB3A-mCherry in RAB3 QKO neurons. Graphical overlay (bottom right)
Y with RIM1a-RZ (white), or NPY with RAB3A and RIM1a-RZ (magenta).
4Cl to visualize all DCVs.
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transmission (Schl€uter et al., 2006). Also, in C. elegans neurons
and mouse chromaffin cells, RAB3 deficiency produces partial
effects on membrane fusion, largely/partially explained by other
defects (impaired vesicle biogenesis; Nonet et al., 1997; Schonn
et al., 2010). The current data indicate that although RAB3s
may not be the (only) unequivocal SEC4p ortholog for synaptic
vesicle fusion, RAB3s are crucial in a late step of the DCV secre-
tory pathway, analogous to its ortholog SEC4p.
To our knowledge, the current study describes the first major
phenotype for RAB3 deficiency in the mammalian brain.
Whereas synaptic vesicle fusion is hardly affected (Schl€uter
et al., 2006), DCV fusion is reduced 20-fold, while the number
of DCVs and their transport were unaffected. RAB3 function
may have become redundant for synaptic transmission alto-
gether, or robust regulation of synaptic vesicle fusion is secured
by emergence of additional paralogs, such as RAB27A/B (Maho-
ney et al., 2006). For DCV fusion and neuromodulator release, no
other (RAB) proteins endogenously expressed in hippocampal
neurons compensate for the loss of RAB3 expression.
Interestingly, while synaptic transmission was largely intact,
several behaviors were altered in RAB3A null mice, including
circadian rhythmicity (Kapfhamer et al., 2002), reversal learning
and exploration (D’Adamo et al., 2004), memory precision (Rue-
diger et al., 2011), and ethanol responses (Kapfhamer et al.,
2002), although other mnemonic capabilities were normal (Hens-
broek et al., 2003). While such effects have been interpreted in
the context of synaptic deficits, for example the loss of mossy fi-
ber LTP in RAB3A KO (Castillo et al., 1997), they are equally
consistent with loss of neuromodulator signaling.
RIM1 Is an Essential RAB3 Effector in and outside
Synapses
The absence of RIM1/2 resulted in a 100-fold reduction in DCV
fusion, which was rescued by RIM1a-RZ, harboring only the
RAB3- and MUNC13-binding domains. Conversely, DCV fusion
was not rescued by re-expression of RIM1b, which binds all
known RIM1 binding partners, except RAB3. Hence, RIM1 is
an essential RAB3A effector for neuromodulator release in hip-
pocampal neurons. The selective loss of RIM2 (i.e., in the pres-
ence of 1 or 2 intact RIM1 alleles) tended to increase DCV fusion
compared to control (Figure S6), suggesting that RIM2 may not
have the same role in neuromodulator release as RIM1 in the
neurons studied here.
The essential role of RIM1 for all neuromodulator release is
unexpected because many DCV fusion events occur outside
synapses, albeit with a low release probability (de Wit et al.,
2009; Persoon et al., 2018; van de Bospoort et al., 2012),
whereas RIM1 is an active zone protein. Fusion events that occur
outside synapses or at dendrites were also absent in RIM1/2-
deficient neurons. Hence, a small number of RIM molecules
may be present at non-synaptic sites to support non-synaptic
DCV fusion. However, despite detailed sub-cellular localization
studies (Tang et al., 2016; Wong et al., 2018), there is no evi-
dence for such non-synaptic localization of RIM1/2. Therefore,
the possibility that RIM1/2 travels on DCVs, probably via RAB3
interaction (Figure 6), and provides on-board support for DCV
fusion is an alternative and possible scenario. While expression
of full-length RIM1 produced cellular levels too low to detect1076 Neuron 104, 1065–1080, December 18, 2019unequivocal co-trafficking, the co-trafficking of the N-terminal
fragment with DCVs was evident (Figure 6), and the efficient
rescue of DCV fusion with this construct (Figure 5) supports
such a scenario. The fact that labeled RIM1 zinc-finger con-
structs travel with a 3-fold larger fraction of DCVs in RIM1/2-defi-
cient neurons than in RAB3 QKO neurons is also consistent with
the idea that endogenous RIM1/2 associates and travels with
DCVs by binding RAB3.
Despite substantial co-trafficking, most DCVs appear to travel
without detectable RIM1a-RZ (Figure 6). However, non-synaptic
DCV fusion is relatively rare (40%) and requires extreme stimula-
tion intensity/frequency (Persoon et al., 2018; van de Bospoort
et al., 2012). The number of RIM1-containing DCVs seems
enough to explain these sparse events. DCV fusion depends
on the t-SNARE SNAP25 (Arora et al., 2017; Shimojo et al.,
2015) and most likely on syntaxins, which are known to be abun-
dantly expressed in axons, also outside synapses (Garcia et al.,
1995). Taken together, these considerations suggest that some
DCVs fuse at non-synaptic sites with a low probability using
RAB3A and possibly RIM1 on the DCV, requiring only cytosolic
molecules and the t-SNAREs at the target membrane, while
most DCVs fuse at synapses exploiting the local enrichment of
RIM1 and t-SNAREs at the target membrane.
The RIM1-MUNC13 Interaction Is Essential for DCV
Fusion and Neuromodulator Release
In RIM1/2-deficient neurons, the loss of neuromodulator release
is effectively rescued with full-length RIM1, but not a RIM1
mutant with two amino acid mutations that prevent MUNC13-1
binding (Figure 3). Moreover, a small N-terminal RIM1 fragment,
containing only the RAB3 andMUNC13-1 binding sites, also res-
cues release, but not when the same fragment contains the same
twomutations (Figure 5). These four observations suggest that in
addition to the essential role of the RAB3-RIM interaction, the
interaction between RIM1 and MUNC13-1 is also essential for
neuromodulator release.
MUNC13-1 levels are from 35% (Figure S4G) to 67% (Deng
et al., 2011) decreased in RIM1/2-deficient hippocampal neu-
rons. The remaining endogenous MUNC13-1 levels apparently
are not sufficient to support neuromodulator release in the
absence of RIMs, and the interaction between the twomolecules
is required, as recently proposed, for synaptic vesicle fusion
(Camacho et al., 2017). RIM1 is considered to disinhibit
MUNC13s by competitive binding to their N-terminal homodime-
rization domain (Camacho et al., 2017; Deng et al., 2011; Dulu-
bova et al., 2005). The fact that full-length MUNC13 is even
more efficient in rescuing neuromodulator release in the absence
of RIM1/2 compared to a MUNC13 mutant lacking this homodi-
merization domain (Figure 4) suggests that, under physiological
conditions, the interaction between RIM1 and MUNC13 and
the disinhibition of MUNC13 may not be essential for neuromo-
dulator release. Alternatively, other factors that monomerize
MUNC13 could be present for DCV but not synaptic vesicles,
or, more trivially, overexpression may have strong gain-of-func-
tion effects on DCV fusion independent of the presence of RIM.
While MUNC13 effectively rescued DCV fusion in RIM-deficient
neurons, the onset of evoked DCV fusion was slow (Figure 4D).
This may be explained by delayed calcium influx, as calcium
responsiveness is not restored by expression of MUNC13 in
RIM-deficient neurons (Deng et al., 2011).
MUNC13 is proposed to tether synaptic vesicles by bridging
between vesicle and plasma membrane via its C2C domain
and C1/C2B domains, respectively (Liu et al., 2016; Rizo,
2018). Such a mechanism may explain why MUNC13 overex-
pression rescues neuromodulator release in the absence of
RIMs: high cellular MUNC13 levels may also bridge between
DCV and plasma membrane and partially compensate for the
loss of the dominant native RIM-RAB3 tethering mechanism
for DCVs. Recruitment of MUNC13 to release sites and
MUNC13 activation may both contribute to the essential role of
RIM1 in DCV fusion.
RAB3/RIM1 Functions Define Diverging Aspects among
CNS-Regulated Secretory Pathways
Secretion of neurotransmitters from synaptic vesicles, of neuro-
modulators from DCVs, and other forms of regulated secretion
most likely emerged from a common ancestral mechanism.
This study reveals several robust molecular differences between
synaptic vesicle and DCV secretory pathways. First, while defi-
ciency for all four RAB3s produces only a mild effect on synaptic
vesicle fusion, DCV fusion is affected by >90%. Second, the role
of RIM’s PDZ domain and its known role in organizing/clustering
Ca2+ channels (Kaeser et al., 2011) is important for synaptic
vesicle, but not DCV, fusion. This is likely because DCV fusion
does not require tight coupling of Ca2+ channels to DCVs before
fusion and is consistent with the observation that DCV fusion re-
lies on Ca2+ buildup during long AP trains, and bypassing Ca2+
channels using ionomycin still produced a >95% reduction of
DCV fusion in RIM1/2 null neurons. Third, RIM’s disinhibition of
MUNC13 is important for synaptic vesicle, but not DCV, fusion
(see above). Fourth, while RIM1’s C2B domain is essential
for RIM’s role in synaptic vesicle fusion by interaction with phos-
phatidylinositol 4,5-bisphosphate (de Jong et al., 2018), this
domain, as well as 80% of RIM1 sequence downstream of the
zinc-finger domain, which also interacts with ELKS, RIM-binding
proteins, and a-liprins (Hibino et al., 2002; Schoch et al., 2002;
Wang et al., 2002), is dispensable for efficient neuromodulator
release. These functional differences suggest that RIM’s two
N-terminal domains are the core domains essential for ancestral
secretion principles and that the rest of the protein contains
evolutionary adaptations that specifically support the ultra-fast,
synchronous fusion of synaptic vesicles in synapses.
In yeast, the six exocyst complex subunits SEC3, 5, 6, 8, 10,
and 15 are essential effectors of SEC4/RAB3 in the last steps
in the secretory pathway, but their orthologs appear not to be
important for regulated secretion in neurons, although available
information is still scarce (Schwenger and Kuner, 2010). In inver-
tebrates, the exocyst complex appears to be dispensable for
synaptic transmission (Mehta et al., 2005; Murthy et al., 2003),
but the RIM orthologs unc10/dRIM are not (Koushika et al.,
2001; Liu et al., 2011), similar to vertebrate synapses and striatal
dopamine varicosities (Deng et al., 2011; Kaeser et al., 2011; Liu
et al., 2018). One possible scenario is that RIMs and MUNC13
have emerged in evolution, between unicellular organisms and
nematodes/flies, as an alternative SEC4/RAB3 effector to the
exocyst complex in regulated secretion. Consistent with thisidea is that the exocyst complex is ubiquitously expressed in
multicellular organisms, but RAB3 and RIM are strongly enriched
in cells that specialize in regulated secretion.
In conclusion, our data show that RAB3A and its effector,
RIM1, are responsible for the regulated secretion of chemical
signals from DCVs in mammalian hippocampal neurons. RIM1
organizes neuromodulator vesicle fusion, also outside synapses,
by positioning or activating MUNC13 and recruiting DCVs
via RAB3s.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Homozygous double conditional RIM1ab/RIM2abgmutant mice described previously (Kaeser et al., 2011; Kaeser et al., 2008) were
used for timed mating of homozygous cDKO mice. All newborn (P1) RIM cDKO mice used for experiments were genotyped by PCR
(Kaeser et al., 2011). RAB3ABCD KO mice have been described previously (Schl€uter et al., 2004). As RAB3ABCD/ embryos die
shortly after birth, embryonic day 18.5 embryos were obtained by caesarean section of pregnant females from timed matings of
RAB3A+/, BCD/ mice and genotyped by PCR as described previously (Schl€uter et al., 2004). C57BL/6 mice were used for
wild-type cultures. For glia preparations newborn pups from femaleWistar rats were used. Animals were housed and bred according
to institutional and Dutch governmental guidelines (DEC-FGA 11-03 and AVD112002017824).
METHOD DETAILS
Primary neuronal cultures
Dissociated hippocampal neuron cultures were prepared from newborn (P1) RIM cDKO mice, E18.5 C57BL/6 (wild-type) or
RAB3A+/, BCD/ littermate mouse embryos. Cerebral cortices were dissected free of meninges in Hanks’ balanced salt solution
(Sigma, H9394) supplemented with 10 mMHEPES (GIBCO, 15630-056). The hippocampi were isolated from the tissue and digested
with 0.25% Trypsin (GIBCO, 15090-046) in Hanks-HEPES for 20 min. at 37C. Hippocampi were washed three times with Hanks-
HEPES and trituratedwith fire-polished glass pipettes. Dissociated neuronswere counted and plated in neurobasal medium (GIBCO,
21103-049) supplemented with 2% B-27 (GIBCO, 17504-044), 1.8% HEPES, 0.25% glutamax (GIBCO, 35050-038) and 0.1% Peni-
cillin-Streptomycin (GIBCO, 15140-122). To obtain single neuron cultures, hippocampal neurons were plated in 12-well plates at a
density of 1100-1400 cells/well on 18 mm glass coverslips containing micro-islands of rat glia. Micro-islands were generated as
described previously (Meijer et al., 2012) by plating 8000/well rat glia on UV-sterilized agarose (Type II-A; Sigma, A9918)-coated
etched glass coverslips stamped with a mixture of 0.1 mg/mL poly-D-lysine (Sigma, P6407), 0.7 mg/mL rat tail collagen (BD Biosci-
ences, 354236) and 10 mM acetic acid (Sigma, 45731). High-density dissociated neuron cultures for protein quantitation and secre-
tionmeasurements were prepared from cortex tissue and plated on plastic 12-wells or 6-wells plates coated with 0.01% poly-L-orni-
thine (Sigma, P4957) and 2.5 mg/mL laminin (Sigma, L2020) diluted in Dulbecco’s phosphate-buffered saline (DPBS; GIBCO, 14190-
250) overnight at RT.
Constructs
EGFP-Cre and EGFP-control (mutant Cre) constructs were created previously (Kaeser et al., 2011) and contained an additional
nuclear localization sequence of nucleoplasmin in the N terminus of EGFP to ensure complete nuclear localization of EGFP. NPY-
pHluorin or NPY-mCherry were generated by replacing Venus in NPY-Venus with super-ecliptic pHluorin or red fluorescent mCherry
(van de Bospoort et al., 2012). Generation of BDNF-pHluorin was described previously (deWit et al., 2009). Synapsin-mCherry was a
kind gift of Dr A. Jeromin (Allen Brain Institute, Seattle, USA) and synapsin-ECFP was obtained by replacing mCherry with ECFP. The
RIM1 rescue constructs RIM1a, RIM1b, RIM1a-DPDZ, RIM1a-K144/6E, RIM1a-RZ, RIM1a-RZ-K144/6E, RIM1b-Z, RIM1b-Z-K144/
6E were described previously (Deng et al., 2011; Kaeser et al., 2011). They were generated from a rat RIM1a or RIM1b expression
plasmid and contained an HA tag. RIM1a-RZ-mCherry or RIM1a-RZ-ECFP were created by adding mCherry or ECFP to the C ter-
minus. The MUNC13-2(WT) and MUNC13-2(DN) constructs were described previously (Deng et al., 2011) and contained mCherry at
the C terminus. RAB3A, B, C and D constructs were obtained from a mouse cDNA library by PCR and labeled with mCherry at the C
terminus. All constructs were cloned to synapsin-promoter driven constructs, sequenced verified and subcloned into pLenti vectors
and viral particles were produced. Titration of lentiviral particle batches was performed by assessment of number of fluorescent cells
upon infection to ensure 100% infection efficiency.
Lentiviral Infection
Neuronal RIM cultures were infected with EGFP-Cre or EGFP-control lentiviral particles at DIV 0 or DIV 5. To visualize DCV fusion and
transport (Figures 2, S3B–S3I, S5B–S5H, and S5M–S5O) cultures were infected with lentiviral particles encoding for NPY-pHluorin,
NPY-mCherry and Syn-ECFP at DIV 9-10. For other DCV fusion experiments cultures were infected at DIV 9-10 with Syn-ECFP and
the DCV reporter NPY-pHluorin or BDNF-pHluorin, allowing single color live cell imaging of DCV fusion and/or the addition of other
constructs. For rescue experiments cultures were infected with the corresponding rescue construct at DIV 0. Neurons were post hoc
fixed and immunostained for the HA-tag present on all rescue constructs to validate expression of rescue constructs in individual
neurons.
Protein quantitation
To characterize protein expression levels of RIM1/2 upon Cre-recombinase expression, high-density dissociated cortical cultures of
RIM cDKOmice were infected at DIV 0 with Cre or control virus. At indicated time-points neurons were washed in cold PBS and ho-
mogenized in Laemmli sample buffer consisting of 2% SDS (VWR chemicals, M107), 10% glycerol (Merck, 818709), 0.26 M b-mer-
captoethanol (Sigma,M3148), 60mMTris-HCl (Serva, 37180) pH 6.8, and 0.01%Bromophenol blue (Applichem, A3640). TomeasureNeuron 104, 1065–1080.e1–e12, December 18, 2019 e3
chromogranin B (CHGB) levels in RAB3 KO neurons, cortex tissue of RAB3A+/+, +/ or /, BCD/ animals was homogenized in
Laemmli sample buffer. Samples were separated on 7% SDS-polyacrylamide gels with 2,2,2-Trichloroethanol using standard
SDS-PAGE technique and scanned in a Gel Doc EZ imager (Bio-Rad). Proteins were transferred to membrane O/N at 150 mA,
4C. Blots were incubated in 2% BSA (Acros Organics, 268131000) - PBS containing 0.1% Tween-20 (Sigma, P2287) for 1 h at
4C. Subsequently blots were incubated with primary antibodies in 2% BSA-PBS-0.1% Tween20 for 4 h at RT. Primary antibodies
included polyclonal rabbit RIM1/2 ZN-finger (1:1000; SySy, 140203), monoclonal mouse b3-Tubulin (1:1000; Cell Signaling, 4466),
polyclonal rabbit Chromogranin B (1:500; SySy 259103) and monoclonal mouse Actin (1:10,000; Chemicon, MAB1501). After
washing with PBS-0.1%Tween-20, blots were incubated with secondary antibodies (anti-rabbit or anti-mouse IRDye secondary an-
tibodies (1:10,000; LI-COR) or alkaline phosphatase-conjugated secondary antibodies (1:10,000; Jackson) in 2% BSA-PBS-0.1%
Tween20 for 45 min. at 4C. After washing blots were scanned with Odyssey FC dual-mode imaging system (LI-COR) for 2 min in
each channel (700 and 800 nm laser). When labeled with alkaline phosphatase-conjugated secondary antibodies, blots were incu-
bated with AttoPhos substrate for 5 min, and scanned on a Fujifilm FLA-5000 Reader.
ELISA
High-density cultures (DIV 8) were washed ones with Tyrode’s solution (119 mM NaCl, 2.5 mM KCl, 2 mM CaCl2*2H20, 2 mM
MgCl2*6H20, 25 mM HEPES and 30 mM Glucose*H20, pH 7.4, mOsmol 280) containing protease inhibitor cocktail (Sigma,
S8830), and subsequently incubated for 1min. with 200 ml Tyrode’s solution and supernatant was collected. Cultures were then incu-
bated for 1 min. with 200 ml Tyrode’s solution containing 60 mM KCl, which replaced NaCl on an equimolar basis in the solution, and
supernatant was collected. Mouse BDNF ELISA (Biosensis, BEK-2003) was used according to the manufacturer’s instructions and
measured with a Spectramax I3 plate reader (Molecular Devices) to quantify BDNF levels in supernatant samples.
Immunocytochemistry
Hippocampal cultures were fixed in 3.7% formaldehyde (Electron Microscopies Sciences, 15680) in PBS, pH 7.4, for 20 min at RT.
After several washing steps with PBS, cells were permeabilized for 5 min with 0.5% Triton X-100 (Fisher Chemical, T/3751/08)-PBS
and subsequently incubated for 30 min. with PBS containing 2% normal goat serum (GIBCO, 16210-072) and 0.1% Triton X-100 to
block nonspecific binding. Incubations with primary and secondary antibodies were performed for 1 h at RT with PBS washing steps
in between. Primary antibodies used were: Polyclonal rabbit Chromogranin B (1:500; SySy 259103), polyclonal chicken MAP2
(1:10,000; Abcam ab5392), monoclonal mouse SMI-312 (1:5000; Covance), polyclonal guinea pig VGLUT1 (1:5000; Millipore
AB5905), monoclonal mouse HA (12CA5, 1:500; Roche 11583816001), monoclonal mouse MUNC13-1 (1:1000; SySy 126111), poly-
clonal guinea pig Synaptophysin1 (1:500; SySy 101004), monoclonal mouse Homer1 (1:500; SySy 160011), monoclonal mouse
PSD95 (1:200; Abcam ab2723). Alexa Fluor conjugated secondary antibodies were from Invitrogen (1:1000). Coverslips werewashed
again andmounted withMowiol 4-88 (Sigma, 81381) and examined on a confocal A1Rmicroscope (Nikon) with LU4A laser unit using
a 40x oil immersion objective (NA = 1.3). Images were acquired at 1024x1024 pixels as z stacks (5 steps of 0.5 mm) and resulting
maximum projection images were used for analysis. A 60x oil immersion objective (NA 1.4) was used for zooms. Confocal settings
were kept constant for all scans within an experiment.
Electron Microscopy
Hippocampal single cultured RIM cDKO neurons (Cre and control infected) were fixed for 60 min. at room temperature with 2.5%
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4), post-fixed for 1 h at room temperature with 1% OsO4/1% K4Ru(CN)6 in double
distilled water. Following dehydration through a series of increasing ethanol concentrations, cells were embedded in Epon and poly-
merized for 24 h at 65C. After polymerization of the Epon, the coverslip was removed by alternately dipping in liquid nitrogen and hot
water. Cells were selected by observing the Epon embedded culture under the light microscope, and mounted on pre-polymerized
Epon blocks for thin sectioning. Ultrathin sections (approximately 70nm) were cut parallel to the cell monolayer and collected on sin-
gle-slot, formvar-coated copper grids, and stained in uranyl acetate and lead citrate.
Synapses were selected at low magnification using a JEOL 1010 electron microscope. All analyses were performed on single
ultrathin sections of randomly selected synapses. Digital images of synapses were taken at 80,000x magnification using iTEM soft-
ware (EMSIS, Germany). For all morphological analyses, we selected only synapses with intact synaptic plasma membranes with a
recognizable pre- and postsynaptic density and clear synaptic vesicle membranes. DCVswere recognized as an electron dense core
surrounded by a vesicular membrane.
Live imaging
Live imaging experiments were performed on a Nikon Ti-E Eclipse inverted microscope system fitted with a Confocal A1R (LU4A
Laser) unit and an EMCCD camera (Andor DU-897). The inverted microscope together with the EMCCD were used for live imaging
using the LU4A laser unit with a 40x oil objective lens (NA 1.3) and appropriate filter sets. NIS elements software (version 4.30)
controlled themicroscope and image acquisition. Coverslips were placed in an imaging chamber and perfusedwith Tyrode’s solution
(119 mMNaCl, 2.5 mM KCl, 2 mMCaCl2*2H20, 2 mMMgCl2*6H20, 25 mMHEPES and 30 mMGlucose*H20, pH 7.4, mOsmol 280).
Isolated single neurons on glial-islands were selected for acquisition and Synapsin-ECFP signal was recorded (z stack, 5 steps of
0.5mm). Time-lapse (2Hz, exposure time dual-color imaging: 80ms per channel, single color imaging: 150 ms) recordings consistede4 Neuron 104, 1065–1080.e1–e12, December 18, 2019
of 30 s baseline recordings followed by stimulation. Electrical field stimulation was applied through parallel platinum electrodes pow-
ered by a stimulus isolator (WPI A385) delivering 30-mA, 1-ms pulses, regulated by aMaster-8 pulse generator (A.M.P.I.) providing 16
trains of 50 action potentials (APs) at 50 Hz with a 0.5 s interval. Chemical stimulation of 5 mM Ionomycin, (Fisher BioReagent) dis-
solved in normal Tyrode’s solution, was applied through glass capillaries placed in close proximity to the cell by gravity flow. To visu-
alize the total pool of NPY-pHluorin, intracellular pH was neutralized by barrel application of normal Tyrode’s solution containing
50mMNH4Cl, which replaced NaCl on an equimolar basis in the solution. To define calcium influx profiles upon stimulation, neurons
were incubated for 15 min with 1 mMFluo-5F-AM (Molecular Probes, F14222; stock in DMSO). Co-trafficking experiments with NPY-
pHluorin were conducted in the presence of normal Tyrode’s solution containing 50 mM NH4Cl, to visualize the total pool of NPY-
pHluorin during the recording. All experiments were performed at RT (20-24C). To ensure expression of HA-tagged rescue con-
structs, coverslips were fixed in 4% PFA-PBS after imaging for immunocytochemistry.
Imaging analysis
Synapse number, DCV poolsize, neuronal morphology
Neuronal morphology and synapse or DCV numbers were analyzed using automated image analysis software synD (Schmitz et al.,
2011). Synapse detection settings were optimized to measure VGLUT1, CHGB puncta or NPY-pHluorin signal and kept constant for
the corresponding dataset. For co-localization analysis of different markers, morphological masks were drawn using SynD and im-
ported in ImageJ to remove background fluorescence. Co-localization was measured in ImageJ with JACoP. Thresholds were set
manually to correct for background.
DCV fusion
DCV fusion events were analyzed in stacks of time-lapse recordings (2 Hz, 512x512 pixels). In ImageJ DCV fusion events weremanu-
ally selected and fluorescent traces were measured in a circular 4x4 pixel ROI (1.56x1.56 mm). NPY-pHluorin or BDNF-pHluorin
events were defined by a sudden increase in fluorescence, NPY-mCherry events as a sudden decrease in fluorescence. Resulting
fluorescent traces were loaded in a custom-built MATLAB plugin where the traces were expressed as fluorescence change (DF)
compared to initial fluorescence (F0) obtained by averaging the first 10 frames of the time-lapse recording. Fusion events were auto-
matically detected and included when fluorescence showed a sudden increase (NPY-pHluorin/BDNF-pHluorin) or a sudden
decrease (NPY-mCherry) two standard deviations above or below F0. Start of a fusion event was defined as the first frame
above/below 2xSD of F0 and end of the fusion event as the first frame below this threshold. Total pool measurements were performed
in SynD on recordings of NPY-pHluorin after application of 50 mM NH4Cl containing Tyrode’s solution to neutralize the intracellular
pH and defined as the number of NPY-pHluorin puncta. For normalization of cumulative number of DCV fusion events over time, each
condition was normalized to 1. The number of DCV fusion events in RAB3 QKO neurons rescued with RAB3A,B,C or D (Figures 1F–
1H) was normalized by dividing the number of fusion events by the cumulative average of RAB3 TKO as control. Co-localization of the
area of a fusion event with synapsin-ECFP (z stacks) was defined as a synaptic event, remaining events were classified as extra-syn-
aptic events. Using ImageJ software binary images of maximum projections of the z stacks were created and events were defined
synaptic if the fluorescent region of the fusion event co-localizedwith Synapsin-ECFP signal. Immunostainings with a panel of endog-
enous pre- and post-synaptic markers (Synaptophysin, VGLUT1 and Homer, PSD95, respectively) on neurons expressing Synapsin-
ECFP (Figure S2A) were used to quantify co-localization of Synapsin-ECFP with these markers, which showed 90% colocalization
with pre-synaptic, and 80% with post-synaptic markers (Figures S2B and S2C).
Calcium imaging
Calciummeasurements were performed in ImageJ. Maximum projections of Synapsin-ECFPwere used to define synaptic and extra-
synaptic regions. Five neurite-located ROIs (4x4 pixels) and a background ROI were measured per neuron. Normalized DF/F0 data
was calculated per cell after background subtraction.
DCV transport
Transport of DCVs in RIM cDKO neurons and controls was measured in time-lapse recordings (2Hz) consisting of 30 s baseline im-
aging, 24 s stimulation (16x50AP at 50Hz) and 30 s imaging after stimulation. Stackswere divided in 20x20 regions (ImageJ, Grid) and
transport was measured in three random regions (coordinates generated by random number generation in MATLAB). NPY-mCherry
labeled vesicles were manually tracked and vesicle trajectories were obtained using the imageJ plugin MtrackJ. If no vesicles were
present in a selected region, the closest region containing DCVs was analyzed. Resulting velocity and distance measurements were
analyzed. A vesicle was regarded as moving when the minimum distance between two consecutive frames was 400 nm (1 pixel) or
more and if the total distance moved from start was at least 800 nm (2 pixels). Kymographs were created in ImageJ (MultipleKymo-
graph, line width 3) to assess colocalization of NPY-pHluorin and RAB3A-mCherry or RIM1a-RZ-mCherry. Colocalization was only
measured in moving NPY-pHluorin puncta. The soma was always excluded from analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
Shapiro-Wilk test was used to assess distribution normality. When assumptions of normality or homogeneity of variances were met,
parametric tests were used: Student’s t test or one-way ANOVA (Tukey as post hoc test). Otherwise, non-parametric tests usedwere:
Mann–Whitney U-test for 2 independent groups, or Kruskal–Wallis with Dunn’s correction for multiple groups. Data are plotted asNeuron 104, 1065–1080.e1–e12, December 18, 2019 e5
mean with standard error of the mean; N represents number of independent experiments, n the number of cells and are indicated in
figures and/or figure legends. Detailed information per dataset (average, SEM, n and detailed statistics) is shown in table below.Dataset Condition
Value
(mean ± SEMs) na p value Statistical test
RAB3ABCD: DCV fusion experiments









**** p < 0.0001 Mann-Whitney
U test





























**** p < 0.0001 Mann-Whitney
U test
DCV fusion events (#) –
NPY
Figure 1H (Raw data)
(1) A+/+, BCD/
(2) ABCD/
(3) ABCD/ + RAB3A
(4) ABCD/ + RAB3B
(5) ABCD/ + RAB3C













ns, p > 0.05: 1 versus 3,
1 versus 5, 1 versus 6,
2 versus 4, 2 versus 5,
2 versus 6, 3 versus 5,
3 versus 6, 4 versus 5,
4 versus 6, 5 versus 6
* p < 0.05: 2 versus 3
** p < 0.01: 1 versus 2,
3 versus 4









(3) ABCD/ + RAB3A
(4) ABCD/ + RAB3B
(5) ABCD/ + RAB3C













ns, p > 0.05: 1 versus 3,
1 versus 5, 1 versus 6,
2 versus 4, 2 versus 5,
2 versus 6, 3 versus 5,
3 versus 6, 4 versus 5,
4 versus 6, 5 versus 6
* p < 0.05: 2 versus 3
** p < 0.01: 1 versus 2,
3 versus 4








(3) ABCD/ + RAB3A
(4) ABCD/ + RAB3B
(5) ABCD/ + RAB3C



















(3) ABCD/ + RAB3A
(4) ABCD/ + RAB3B
(5) ABCD/ + RAB3C













ns, p > 0.05: 1 versus 2,
1 versus 3, 1 versus 4,
1 versus 5, 1 versus 6,
2 versus 4, 2 versus 5,
2 versus 6, 3 versus 5,
4 versus 5, 4 versus 6,
5 versus 6
* p < 0.05: 2 versus 3,
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(1) Endogenous RAB3A -
synaptic, extra-synaptic
(2) ABCD/ + RAB3A-
synaptic, extra-synaptic
(3) ABCD/ + RAB3B-
synaptic, extra-synaptic
(4) ABCD/ + RAB3C-
synaptic, extra-synaptic






















1: synaptic versus extra-
synaptic: **** p < 0.0001
2: synaptic versus extra-
synaptic:
**** p < 0.0001
3: synaptic versus extra-
synaptic:
**** p < 0.0001
4: synaptic versus extra-
synaptic:
**** p < 0.0001
5: synaptic versus extra-
synaptic:































ns, p > 0.05 Kruskal-Wallis with
Dunn’s correction












































ns, p > 0.05: 3 versus 4
**p < 0.0073: 1 versus 2
Mann-Whitney
U test






































ns, p > 0.05: 1 versus 3
* p < 0.05: 2 versus 3


























ns, p > 0.05: 1 versus 3
* p < 0.05: 2 versus 3
** p < 0.01: 1 versus 2
Kruskal-Wallis with
Dunn’s correction
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ns, p > 0.05: 1 versus 2,
1 versus 3
* p < 0.05: 2 versus 3
Kruskal-Wallis with
Dunn’s correction












ns, p > 0.05: 1 versus 3,
2 versus 3













ns, p > 0.05: 1 versus 2


















ns, p = 0.5231 Kruskal-Wallis with
Dunn’s correction
RIM 1/2: DCV fusion experiments




















**** p = < 0.0001 Mann-Whitney
U test


















ns, p = 0.0508 Mann-Whitney
U test









****p < 0.0001 Mann-Whitney
U test





(4) cDKO + RIM1b
(5) cDKO + RIM1a-
DPDZ














ns, p > 0.05: 1 versus 3,
1 versus 4, 1 versus 5,
2 versus 6, 3 versus 4,
3 versus 5, 4 versus 5,
4 versus 6, 5 versus 6
*p < 0.05: 1 versus 6,
3 versus 6
**p < 0.01: 2 versus 4,
2 versus 5









(4) cDKO + RIM1b
(5) cDKO + RIM1a-
DPDZ














ns, p > 0.05 Kruskal-Wallis with
Dunn’s correction
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(2) cDKO + RIM1b:
synaptic, extra-synaptic
(3) cDKO + RIM1a-
DPDZ:
synaptic, extra-synaptic



















1: synaptic versus extra-
synaptic: **** p < 0.0001
2: synaptic versus extra-
synaptic:
**** p < 0.0001
3: synaptic versus extra-
synaptic:
**** p < 0.0001
4: synaptic versus extra-
synaptic:
**** p < 0.0001
Mann-Whitney
U test
DCV fusion events (#)
Figure 3I
Control (5 mM Ionomycin)






*** p = < 0.0007 Mann-Whitney
U test
Total DCV pool (#)
Figure S6M
Control (5 mM Ionomycin)





ns, p = 0.3229 Student’s t test




(3) cDKO + RIM1a
(4) cDKO+ Munc13-2 (WT)











ns, p > 0.05: 1 versus 3,
1 versus 4, 1 versus 5,
2 versus 5, 3 versus 4,
3 versus 5, 4 versus 5
*p < 0.05: 2 versus 4
** p < 0.01: 2 versus 3
*** p < 0.001: 1 versus 2
Kruskal-Wallis with
Dunn’s correction




(3) cDKO + RIM1a
(4) cDKO+ Munc13-2 (WT)
















(1) cDKO+ Munc13-2 (WT):
Synaptic,












1: ns, p = 0.0556
2: ns, p = 0.1060
1: Mann-Whitney
U test
2: Student’s t test

























ns, p > 0.05: 1 versus 3,
1 versus 4, 2 versus 4,
2 versus 5, 2 versus 6,
2 versus 7, 3 versus 4,
3 versus 7, 4 versus 5,
4 versus 6, 4 versus 7,
5 versus 6, 5 versus 7,
6 versus 7
*p < 0.05: 1 versus 7
** p < 0.01: 1 versus 5,
3 versus 5
*** p < 0.001: 1 versus 2,
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(mean ± SEMs) na p value Statistical test

























ns, p > 0.05: 1 versus 2,
1 versus 3, 1 versus 4,
1 versus 5, 1 versus 6,
1 versus 7, 2 versus 4,
2 versus 5, 2 versus 6,
2 versus 7, 3 versus 4,
3 versus 6, 3 versus 7,
4 versus 5, 4 versus 6,
4 versus 7, 5 versus 6,
5 versus 7, 6 versus 7
*p < 0.05: 3 versus 5






































1: synaptic versus extra-
synaptic: *** p < 0.0002
2: synaptic versus extra-
synaptic:
**** p < 0.0001
3: synaptic versus extra-
synaptic:
*** p < 0.0001
4: synaptic versus extra-
synaptic:
** p = 0.0043
5: synaptic versus extra-
synaptic: ns, p = 0.060





















ns, p > 0.05: 1 versus 2,
1 versus 3, 1 versus 4,
2 versus 3, 2 versus 4,
3 versus 4, 3 versus 5,
4 versus 5
*p < 0.05: 2 versus 5
**p < 0.01: 1 versus 5
Kruskal-Wallis with
Dunn’s correction





































ns, p > 0.5027 Kruskal-Wallis with
Dunn’s correction
DCV fusion events (#) -








** p < 0.01 Mann-Whitney
U test









ns, p = 0.667 Mann-Whitney
U test




















ns, p = 0.438 Mann-Whitney
U test
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(mean ± SEMs) na p value Statistical test
Velocity (mm/s)
Figure S5E
(1) Control – before
stimulation
(2) RIM cDKO – before
stimulation
(3) Control – during
stimulation
(4) RIM cDKO – during
stimulation
(5) Control – after
stimulation














ns, p = 0.2424 (1 versus 2)
ns, p = 0.1991 (3 versus 4)











ns, p = 0.502 Mann-Whitney
U test













































































ns, p = 0.25 Mann-Whitney
U test
















































ns, p > 0.05 Student’s t test








ns, p = 0.0571 Mann-Whitney
U test
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(mean ± SEMs) na p value Statistical test
Synapse number -








ns, p = 0.67 Mann-Whitney
U test
Dendritic length (mm) -








ns, p = 0.92 Mann-Whitney
U test
Synapse number per mm








ns, p = 0.457 Student’s t test
VGLUT1 intensity (F)-




















* p < 0.05: 1 versus
2 ns, p > 0.05: 1
versus 3, 2 versus 3
Kruskal-Wallis with
Dunn’s correction
an = number of experiments (cells); unless otherwise indicated
bns = non-significantDATA AND CODE AVAILABILITY
The data that support the findings of this study are available from the Lead Contact upon reasonable request.e12 Neuron 104, 1065–1080.e1–e12, December 18, 2019
